E-LIB Suche - Ergebnisse für: Arance, Ana

1

ASO Visual Abstract: Efficacy and Safety of Melphalan/Hepat..:

Zager, Jonathan S. ; Orloff, Marlana ; Ferrucci, Pier Francesco...
Annals of Surgical Oncology. , 2024

Link: https://doi.org/10.1245/..

2

Genomic deletions explain the generation of alternative BRA..:

Aya, Francisco ; Lanuza-Gracia, Pablo ; González-Pérez, Abel...
Cell Reports. 43 (2024) 4 - p. 114048 , 2024

Link: https://doi.org/10.1016/..

3

COLUMBUS 7-year update: A randomized, open-label, phase III..:

Schadendorf, Dirk ; Dummer, Reinhard ; Flaherty, Keith T....
European Journal of Cancer. 204 (2024) - p. 114073 , 2024

Link: https://doi.org/10.1016/..

4

Predictive and Prognostic Factors in Melanoma Central Nervo..:

Serra, Estefania ; Abarzua-Araya, Álvaro ; Arance, Ana...
Cancers. 16 (2024) 12 - p. 2272 , 2024

Link: https://doi.org/10.3390/..

5

Efficacy and Safety of the Melphalan/Hepatic Delivery Syste..:

Zager, Jonathan S. ; Orloff, Marlana ; Ferrucci, Pier Francesco...
Annals of Surgical Oncology. , 2024

Link: https://doi.org/10.1245/..

6

Feasibility and Impact of Embedding an Extended DNA and RNA..:

Castrejon, Natalia ; Martin, Roberto ; Carrasco, Antonio...
International Journal of Molecular Sciences. 25 (2024) 13 - p. 6942 , 2024

Link: https://doi.org/10.3390/..

7

Management of infliximab refractory immune checkpoint inhib..:

Harvey, Catriona ; Nahar, Kazi J ; McKeown, Janet...
Journal for ImmunoTherapy of Cancer. 12 (2024) 1 - p. e008232 , 2024

Link: https://doi.org/10.1136/..

8

Sequential immunotherapy and targeted therapy for metastati..:

Ascierto, Paolo A. ; Casula, Milena ; Bulgarelli, Jenny...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

9

Encorafenib and binimetinib followed by radiotherapy for pa..:

Márquez-Rodas, Iván ; Álvarez, Ana ; Arance, Ana...
Neuro-Oncology. , 2024

Link: https://doi.org/10.1093/..

10

Efficacy and safety of immune checkpoint inhibitors in youn..:

Wong, Selina K. ; Blum, Steven M. ; Sun, Xiaopeng...
European Journal of Cancer. 181 (2023) - p. 188-197 , 2023

Link: https://doi.org/10.1016/..

11

A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab..:

Weiss, Sarah A. ; Sznol, Mario ; Shaheen, Montaser...
Clinical Cancer Research. 30 (2023) 1 - p. 74-81 , 2023

Link: https://doi.org/10.1158/..

12

A plain language summary of the 5-year update from part 1 o..:

Dummer, Reinhard ; Flaherty, Keith T ; Robert, Caroline...
Future Oncology. 19 (2023) 16 - p. 1091-1098 , 2023

Link: https://doi.org/10.2217/..

13

Immunophenotype of tumor-infiltrating lymphocytes in atypic..:

Moysset, Irene ; Fuster-Anglada, Carla ; Castillo, Paola...
Annals of Diagnostic Pathology. 60 (2022) - p. 151985 , 2022

Link: https://doi.org/10.1016/..

14

Corrigendum to 'Quality of life in patients with BRAF-mutan..:

Gogas, Helen ; Dummer, Reinhard ; Ascierto, Paolo A....
European Journal of Cancer. 160 (2022) - p. 287-288 , 2022

Link: https://doi.org/10.1016/..

15

Timeline of Adverse Events during Immune Checkpoint Inhibit..:

Villa-Crespo, Lorena ; Podlipnik, Sebastian ; Anglada, Natalia...
Cancers. 14 (2022) 5 - p. 1237 , 2022

Link: https://doi.org/10.3390/..